欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/7074/001
药品名称Sugammadex Vivanta 100 mg/ml Injektionslösung
活性成分
    • Sugammadex sodium 100.0 mg/ml
剂型Solution for injection
上市许可持有人Vivanta Generics s.r.o. Trtinová 260/1 196 00 CAKOVICE, PRAHA 9 Czech Republic Czechia
参考成员国 - 产品名称Germany (DE)
Sugammadex Vivanta 100 mg/ml Injektionslösung
互认成员国 - 产品名称
    • France (FR)
    • Ireland (IE)
    • Portugal (PT)
    • Spain (ES)
    • Poland (PL)
      Sugammadex MSN
    • Cyprus (CY)
      Sugammadex MSN 100mg/ml solution for injection
    • Latvia (LV)
    • Lithuania (LT)
      Sugammadex MSN 100 mg/ml injekcinis tirpalas
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
    • Slovenia (SI)
    • Malta (MT)
      MA1478/00701-2
    • Croatia (HR)
    • Netherlands (NL)
许可日期2023/05/17
最近更新日期2025/12/16
药物ATC编码
    • V03AB35 sugammadex
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase